Analysis and Screening of Bioactive Components in Chinese Herbal Medicines by Hplc and Hyphenated Techniques

Li P,Qi L W,Zhou J L
DOI: https://doi.org/10.1055/s-2009-1216433
IF: 3.007
2009-01-01
Planta Medica
Abstract:The idea of combination therapy has been practiced in Traditional Chinese Medicine for thousands of years, and has been gaining ever-increasing acceptance in the world. During the past decade, owing to changes in the types of disease and limitations of Western medicine, the usage of Chinese herbal medicines (CHMs) has expanded globally. CHMs are complex mixtures consisting of thousands of compounds. Getting useful chemical and bioactive information from these highly complicated matrices has long been one of the major challenges to chemists, analysts, biologists and pharmacologists. The speaker, Prof. Li, is the head of Key Laboratory of Modern Chinese Medicine, Ministry of Education, and the director of Department of Phamarcognosy at the China Pharmaceutical University and has been working in the field of CHMs for over 20 years. The most often used instrumental technique, high-performance liquid chromatography (HPLC) remains unchallenged for the analysis of CHMs, because of it is low-cost, readily availability and easy of use. This report covers current HPLC-based strategies for the analysis of CHMs, and is divided into three major sections. These are simultaneous qualitation and quantification of various components in CHMs (in vitro), metabolite identification and pharmacokinetic investigation of CHMs' components in biological samples (in vivo), and biomacromolecule (protein and DNA) affinity/LC-MS for screening of multiple bioactive candidates in CHMs. Acknowledgements: Financial support for this research from the National Science Foundation of China (No. 90709020, 30530870) is gratefully acknowledged.
What problem does this paper attempt to address?